M Boisseau, R Bugat, M Mahjoubi. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Adenocarcinoma/drug therapyAdenocarcinoma/secondaryAdultAntineoplastic Agents, Phytogenic/adverse effectsCamptothecin/adverse effectsCamptothecin/analogs & derivativesColonic Neoplasms/drug therapyColonic Neoplasms/pathologyFatal OutcomeFemaleHumansIrinotecanTumor Lysis Syndrome/etiology
Substances: See more » Antineoplastic Agents, PhytogenicIrinotecanCamptothecin
Year: 1996 PMID: 8695285 DOI: 10.1016/0959-8049(95)00654-0
Source DB: PubMed Journal: Eur J Cancer ISSN: 0959-8049 Impact factor: 9.162